Skip Navigation Links

Webinar: New FOA on Clinical Trial Development 

December 3, 2018
photo of calculator and stethoscope

A new Funding Opportunity Announcement (FOA) is available for development of the essential elements of a clinical trial that will support NINR’s mission.  

The FOA uses the R34 activity code, which provides support for the initial development of a clinical trial including the establishment of the research team; the development of tools for data management and oversight of the research; the development of a trial design and other essential elements of the study or project, such as the protocol, recruitment strategies, procedure manuals, and collection of feasibility data. 

To learn more about this FOA, view the webinar from December 11, 2018. 

If you have additional questions, please contact Karen Huss, PhD at 301-594-5970 or 

Arrow Up Back to Top